Therefore, limiting inflammatory cytokine production in reactive astrocytes via APE1/Ref-1 activity expected to be beneficial for the prevention of neuroinflammation and neurodegeneration in various brain diseases. This evidence concerns the gene APEX1 and brain disorder.